Yissum's new Ag-bio fund supports earlt-stage projects in the promising Agricluture field. 

Atox Bio is focused on the discovery and development of therapeutics for the treatment of infectious and autoimmune diseases mediated by excessive T-cell response. Having developed novel immunomodulators that reduce autoimmune response, as well as novel antagonists that block the action of a family of deadly bacterial toxins termed super antigens, Atox Bio is developing products for treatment of: Infectious diseases - toxic shock (including a biodefense countermeasure against super antigen toxins) and Gram-positive septic shock, both of which are lethal and constitute a strong unmet medical need; Autoimmune diseases - including rheumatoid arthritis, multiple sclerosis and psoriasis.

Apertio develops data discovery, integration and sharing solutions in two domains: Open Data (datasets published on the web by government and non-government organizations) and Closed Data (datasets published internally by large government agencies and private sector corporations).

Accelerating Growth of Farmed Fish
With feed comprising 30%-50% of growers' operating expenses, the goal of reaching maximum fish weight while reducing production costs is a key challenge. AquiNovo's technology addresses this challenge by inhibiting fish reproduction, thus channeling the fish’s energy to accelerate growth and reach market weight faster. The technology provides a non-GMO, non-hormonal solution for enhancing fish growth.

BactuSense develops a nanotechnology solution for bacteria detection in any liquid. The Bactusense optical biosensor uses silicon-based microchips to detect and identify bacteria in the liquid passing through the system.
The system can work in different variations to identify specific kinds of bacteria in water, air, food, and body fluids, and can be applied in a variety of industries such as food-processing plants, hospitals, and municipal water supplies.

Beeologics LLC is an international firm dedicated to restoring bee health and protecting the future of honey bee pollination. Beeologics’ mission is to become the guardian of bee health worldwide.
Beeologics was aquired by Monsanto in 2011

Betalin Therapeutics is developing an Engineered Micro Pancreas (EMP) to improve the quality of life for millions of people with diabetes. 
Betalin Therapeutics licensed the novel EMP technology developed at The Hebrew University of Jerusalem, Israel, in an exclusive worldwide agreement in 2015. The Hebrew University continues to partner with Betalin Therapeutics to support the research and development.

BioCancell is specializing in the development of patient-oriented, targeted therapy for the treatment of a wide range of cancers. Its therapeutic and diagnostic technology constitutes a novel 'search and destroy' paradigm for the targeted destruction of cancer cells - with no effect on surrounding tissue and no observed side effects - for long-term, safe treatment and prevention of cancer.

BioNanoSim Ltd., (BNS) is an upscale company manufacturing nano-based delivery systems which are uniquely challenging for pharmaceutical development especially the production of polymeric biodegradable nanoparticles (NPs). Such NPs, once drug- loaded, integrated into an appropriate medium, and administered can potentially find their target and release their load at a regulated rate, ensuring prolonged and precise treatment.
Our efforts will focus on translating our academic knowledge into promising good manufacturing  practice clinical-stage products for improving the performance of potent drugs, drug targeting and identifying new indications for existing drugs exploiting the benefits of nanotechnology.

BriefCam is an early stage start-up company, established to develop and commercialize video synopsis, summarization and indexing technology. The initial technology of video synopsis was developed at The Hebrew University of Jerusalem, and is licensed by BriefCam.

BreedIT ltd. is an emerging Israeli provider of advanced agro breeding information technologies, support and integration systems, aimed at assisting plant breeders to plan, manage and analyze their breeding data and to perform research activities quickly and effectively.

The world's first accurate, affordable and easy-to-use device, for the non-destructive detection, analysis and automated sorting of individual medical cannabis flowers. The Company's proprietary technology combines Near Infra-Red (NIR) spectrometry and imaging tools to provide a sensitive method to detect and quantify the active compounds of the cannabis plant and a unique spectral fingerprint for each flower. 

CollPlant is developing a production system in transgenic tobacco to manufacture human recombinant collagen I with improved thermal stability.

An Israeli biotechnology company engaged in the discovery and manufacture of new advanced breeding solutions to improve traits in crops for the world agricultural community's needs.

Ex Libris is a leading developer and provider of high-performance applications for libraries, information centers, and researchers. The company's products include ALEPH, an integrated library solution; MetaLib(R), an information portal for library collections; SFX(R), a context-sensitive linking solution for heterogeneous electronic resources in the scholarly information environment; DigiTool(R), a solution for the construction of digital collections; Verde(R), an electronic resource management (ERM) system; and Primo(R), a next-generation, user-centric discovery and delivery solution.

FICOS is developing a system to help prevent fires in electrical enclosures before they happen. By using an array of small wireless modules placed at regions of potential overheating, the system can detect a problem before it gets out of hand.

In a world challenged by growing population, diminishing resources and climate change, FuturaGene’s technologies address critical challenges of plant yield enhancement and yield protection.
Futuragene harness biotechnology to ensure the security and sustainability of Fiber, Fuel, and Feed.

A medical device company developing a guided intubation system. The system enables a clear identification of the trachea during intubation procedures and leads the caregiver to it even in difficult situations where visualization of the trachea is limited.

Next-Generation Accelerators for Proton-Beam Therapy

HumanEyes introduces software products that enable the simple creation of panoramic 3D stereo images from ordinary photographs captured by any single still or video digital camera